| Financial Year |
March 31 2023 |
| Monetary Funds |
410,566,758.95 |
| Held-for-trading Financial Assets |
129,500,000.00 |
| Notes Receivable |
60,027,159.86 |
| Accounts Receivable |
74,892,290.55 |
| Advances to Suppliers |
1,158,664.91 |
| Other Receivables |
63,217.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
38,732,914.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
714,941,006.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,903,197.97 |
| Fixed Assetes |
71,575,411.49 |
| Under-construction Projects |
27,847,468.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,300,482.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,957,941.60 |
| Deferred Income Tax Assets |
2,923,876.94 |
| Other Non-Current Assets |
36,919,070.03 |
| Sub-Total of Non-Current Assets |
205,651,340.42 |
| Total Assets |
920,592,347.10 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,120,000.00 |
| Accounts Payable |
18,372,461.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,447,107.62 |
| Taxes Payable |
6,390,863.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,479,170.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,075,812.17 |
| Sub-Total of Current Liabilities |
40,871,767.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,901.77 |
| Deferred Income Tax Liabilities |
2,851,543.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,799,974.91 |
| Total Liabilities |
46,671,742.46 |
| Paid-In Capital(Or Share Stock) |
156,811,200.00 |
| Capital Surplus |
524,130,112.90 |
| Surplus Reserve |
38,837,032.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
153,101,950.79 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
873,920,604.64 |
| Owner's Equity（Stockholder's Equity） |
873,920,604.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
920,592,347.10 |
